跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,452 条关于
“GIP-dependent Cushing's Syndrome”
全部
40,452
临床试验
34,396
药物
782
机构
44
资讯
5,230
2个月前
Vogenx raises $81.3M in Nasdaq IPO to advance SGLT1 inhibitor mizagliflozin in metabolic disorders
去年
Clofutriben Shows Promise in Phase 2 Trial for Endogenous Cushing's Syndrome
去年
FDA Expands Osilodrostat (Isturisa) Indication for Broader Cushing's Syndrome Treatment
7天前
FDA Grants Orphan Drug Designation to Lundbeck's Anti-ACTH Antibody Asedebart for Endogenous Cushing's Syndrome
去年
Corcept Therapeutics Submits New Drug Application for Relacorilant to Treat Cushing's Syndrome
2年前
Crinetics' Atumelnant Shows Promise in Congenital Adrenal Hyperplasia and Cushing's Syndrome
去年
Sterotherapeutics Launches Phase 2 Trial of Novel Cushing's Syndrome Treatment ST-002
去年
Relacorilant Shows Durable Cardiometabolic Benefits in Cushing's Syndrome Patients
去年
Sterotherapeutics Doses First Patient in Phase 2 Trial of ST-002 for Cushing's Syndrome
去年
Corcept's Relacorilant Shows Promise in Cushing's Syndrome Treatment
第 1 页，共 523 页
上一页
下一页
